celecoxib has been researched along with cyclin d1 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 10 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aggarwal, BB; Shishodia, S | 1 |
| Aggarwal, BB; Koul, D; Shishodia, S | 1 |
| Chan, AT; Chan, CM; Ma, BB; Wong, SC | 1 |
| Dai, CW; Li, RJ; Liu, DS; Zhang, GS | 1 |
| Fukada, K; Iida, M; Miwa, Y; Morimoto, S; Sakoguchi-Okada, N; Sasaguri, T; Shiraishi, F; Taba, Y; Takahashi-Yanaga, F | 1 |
| Bosland, MC; Horton, L; Narayanan, BA; Narayanan, NK; Nargi, D; Randolph, C; Reddy, BS | 1 |
| Sasaguri, T; Takahashi-Yanaga, F | 1 |
| Kazi, JU; Li, H; Soh, JW; Thompson, WJ; Weinstein, IB | 1 |
| Bottini, C; Fantappiè, O; Mazzanti, R; Platini, F; Solazzo, M; Tessitore, L | 1 |
| Burmeister, CB; Gee, JR; Havighurst, TC; Kim, K | 1 |
| Jiang, HR; Li, W; Liu, ML; Wang, J; Xu, XL; Zhai, LY; Zhang, J | 1 |
| Fang, XM; Han, M; Li, BH; Liu, B; Shi, CJ; Wang, JJ; Wen, JK; Zhang, DQ; Zhang, YP | 1 |
| Cerella, C; Dicato, M; Diederich, M; Sobolewski, C | 1 |
| Hu, GQ; Hu, GY; Liu, DB; Long, GX; Mei, Q; Qiu, H | 1 |
| Cai, JH; Li, W; Tang, YX; Wan, L; Zhang, J | 1 |
| Abrahão, AC; Giudice, FS; Pinto Junior, Ddos S; Sperandio, FF | 1 |
| Huang, Y; Li, W; Liao, W; Yan, Y | 1 |
| Hur, DY; Jin, DH; Kim, D; Kim, JE; Kim, S; Kim, YS; Lee, JI; Lee, WJ; Park, GB; Wu, TC | 1 |
| Cerella, C; Dicato, M; Diederich, M; Muller, F; Sobolewski, C | 1 |
| Geng, RL; Hao, HL; Li, J; Wang, C; Wang, RC; Wang, SY; Xie, X; Zhao, XY | 1 |
1 review(s) available for celecoxib and cyclin d1
| Article | Year |
|---|---|
GSK-3beta regulates cyclin D1 expression: a new target for chemotherapy.
Topics: Animals; Antineoplastic Agents; beta Catenin; Celecoxib; Cell Cycle; Cell Differentiation; Curcumin; Cyclin D1; Dyrk Kinases; Enzyme Activation; Enzyme Activators; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Pyrazoles; Retinoids; Signal Transduction; Sulfonamides; Transcription, Genetic; Ubiquitins; Wnt Proteins | 2008 |
19 other study(ies) available for celecoxib and cyclin d1
| Article | Year |
|---|---|
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: correlation with suppression of cyclin D1, COX-2
Topics: Carcinoma, Non-Small-Cell Lung; Celecoxib; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; I-kappa B Kinase; Isoenzymes; Lung Neoplasms; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Membrane Proteins; NF-kappa B; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Serine-Threonine Kinases; Pyrazoles; Smoke; Smoking; Sulfonamides | 2004 |
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Topics: Carcinogens; Carcinoma, Non-Small-Cell Lung; Celecoxib; Cell Line, Tumor; Cyclin D1; Cyclooxygenase Inhibitors; Enzyme Activation; Genes, Reporter; Humans; I-kappa B Kinase; I-kappa B Proteins; Interleukin-1; Lipopolysaccharides; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase Inhibitors; Neoplasm Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Okadaic Acid; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptors, Tumor Necrosis Factor; Sulfonamides; Tetradecanoylphorbol Acetate; TNF Receptor-Associated Factor 1; TNF Receptor-Associated Factor 2; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2004 |
Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression.
Topics: Blotting, Western; Celecoxib; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Humans; Nasopharyngeal Neoplasms; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Tetrazolium Salts; Thiazoles | 2005 |
Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Bone Marrow Cells; Caspase 3; Caspase Inhibitors; Caspases; Celecoxib; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Enzyme Activation; Enzyme Inhibitors; G1 Phase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; Hydroxyurea; Imatinib Mesylate; Interleukin-1; Intracellular Signaling Peptides and Proteins; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Proteins; Piperazines; Pyrazoles; Pyrimidines; S Phase; Sulfonamides | 2006 |
Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Celecoxib; Colonic Neoplasms; Cyclin D1; Gene Expression; Humans; Inhibitor of Apoptosis Proteins; Microtubule-Associated Proteins; Neoplasm Proteins; Promoter Regions, Genetic; Pyrazoles; RNA, Messenger; Signal Transduction; Sulfonamides; Survivin; TCF Transcription Factors; Tumor Cells, Cultured; Wnt Proteins | 2007 |
Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; ErbB Receptors; Humans; Male; Methylnitrosourea; Prostatic Neoplasms; Pyrazoles; Rats; Rats, Wistar; Receptors, Androgen; Sulfonamides; Sulindac; Testosterone | 2007 |
Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
Topics: Apoptosis; Celecoxib; Cell Adhesion Molecules; Cell Proliferation; Colonic Neoplasms; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 2; Cyclin D1; Cyclooxygenase Inhibitors; Enzyme Activation; Humans; Indomethacin; Lactones; Meclofenamic Acid; Microfilament Proteins; Mitogen-Activated Protein Kinase 8; Phosphoproteins; Phosphorylation; Pyrazoles; Sulfonamides; Sulfones; Tumor Cells, Cultured | 2008 |
Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Celecoxib; Cell Cycle; Cell Division; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase Inhibitors; Drug Resistance, Multiple; G1 Phase; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Hepatocyte Growth Factor; Humans; Liver Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; RNA, Neoplasm; RNA, Small Interfering; Sulfonamides | 2009 |
Cyclin-mediated G1 arrest by celecoxib differs in low-versus high-grade bladder cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Celecoxib; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cyclin B1; Cyclin D1; Cyclooxygenase 2; G1 Phase; Humans; Pyrazoles; Retinoblastoma Protein; Sulfonamides; Urinary Bladder Neoplasms | 2009 |
Cyclin D1 expression and the inhibitory effect of celecoxib on ovarian tumor growth in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Female; Humans; Mice; Neoplasms, Experimental; Ovarian Neoplasms; Pyrazoles; RNA, Messenger; Sulfonamides; Xenograft Model Antitumor Assays | 2010 |
Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms.
Topics: Animals; Apoptosis; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drugs, Chinese Herbal; Female; G1 Phase; Humans; Lactones; Mice; Mice, Nude; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Pyrazoles; Resting Phase, Cell Cycle; Signal Transduction; Sulfonamides; Transplantation, Heterologous | 2011 |
Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells.
Topics: Antigens, Differentiation; Apoptosis; Biomarkers; Celecoxib; Cell Differentiation; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Gene Expression Regulation, Leukemic; Humans; Interphase; Jurkat Cells; K562 Cells; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Pyrazoles; Sulfonamides; U937 Cells; Up-Regulation | 2011 |
Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma; Celecoxib; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Interleukin-6; Myeloid Cell Leukemia Sequence 1 Protein; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Pyrazoles; Signal Transduction; STAT3 Transcription Factor; Sulfonamides; Time Factors | 2012 |
Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Celecoxib; Cell Proliferation; Cyclin D1; Cyclooxygenase Inhibitors; Female; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Mice; Mice, Nude; Ovarian Neoplasms; Paclitaxel; Pyrazoles; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2012 |
Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Squamous Cell; Celecoxib; Cell Culture Techniques; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pyrazoles; Signal Transduction; Sulfonamides | 2013 |
[Celecoxib enhances chemosensitivity of oral cancer cells by blocking cell cycle progression in vitro].
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Celecoxib; Cell Cycle; Cell Line, Tumor; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Drug Resistance, Neoplasm; Humans; KB Cells; Mouth Neoplasms; Pyrazoles; Sulfonamides | 2013 |
Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Boronic Acids; Bortezomib; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclooxygenase 2 Inhibitors; Down-Regulation; Endoplasmic Reticulum Stress; Female; G1 Phase Cell Cycle Checkpoints; Imidazoles; Mice; Mice, Inbred C57BL; Oncogene Proteins, Viral; p38 Mitogen-Activated Protein Kinases; Papillomavirus E7 Proteins; Pyrazines; Pyrazoles; Pyridines; Repressor Proteins; STAT3 Transcription Factor; Sulfonamides; Transcription Factor CHOP; Uterine Cervical Neoplasms | 2014 |
Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model.
Topics: Apoptosis; Celecoxib; Cell Cycle; Cell Line, Tumor; Curcumin; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Humans; Jurkat Cells; K562 Cells; U937 Cells | 2015 |
[Effect of COX-2 inhibitor celecoxib on proliferation, apoptosis of HL-60 cells and its mechanism].
Topics: Apoptosis; Celecoxib; Cell Proliferation; Cyclin D1; Cyclin E; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Oncogene Proteins; Pyrazoles; Sulfonamides | 2014 |